Inovio Pharmaceuticals
INO
$10.57
Share price
4.40%
Change (1 day)
1,255.13%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - P/B ratio
P/B ratio as of April 2024 : 2.34
According to Inovio Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 2.34.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Inovio Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.19 | -32.22% |
| 2022-12-31 | 1.75 | -33.37% |
| 2021-12-31 | 2.63 | -19.21% |
| 2020-12-31 | 3.25 | -94.75% |
| 2019-12-31 | 61.9 | 1284.97% |
| 2018-12-31 | 4.47 | 70.73% |
| 2017-12-31 | 2.62 | -37.18% |
| 2016-12-31 | 4.17 | 51.02% |
| 2015-12-31 | 2.76 | -44.82% |
| 2014-12-31 | 5.00 | -56.64% |
| 2013-12-31 | 11.5 | 457.47% |
| 2012-12-31 | 2.07 | 81.71% |
| 2011-12-31 | 1.14 | -55.62% |
| 2010-12-31 | 2.56 | 33.96% |
| 2009-12-31 | 1.91 | 59.82% |
| 2008-12-31 | 1.20 | -7.77% |
| 2007-12-31 | 1.30 | -73.97% |
| 2006-12-31 | 4.99 | 75.05% |
| 2005-12-31 | 2.85 | -38.94% |
| 2004-12-31 | 4.67 | -11.77% |
| 2003-12-31 | 5.29 | 39.65% |
| 2002-12-31 | 3.79 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 118.50% | 🇺🇸 USA |
 Novartis NVS | 4.25 | 81.48% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | -31.29% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.59 | 53.01% | 🇺🇸 USA |
 Merck MRK | 8.83 | 276.79% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.16 | 120.39% | 🇬🇧 UK |
 Arrowhead Pharmaceuticals
ARWR | 15.8 | 573.53% | 🇺🇸 USA |